Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed director
Quarterly results
Director departure
|
|
TENAX THERAPEUTICS, INC. (TENX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/30/2021 |
8-K/A
| Quarterly results |
| 11/08/2019 |
8-K/A
| Submission of Matters to a Vote of Security Holders |
| 01/22/2014 |
8-K/A
| Financial Statements and Exhibits|
Docs:
|
"Consent of WithumSmith+Brown, PC",
"Audited Financial Statements of Phyxius Pharma, Inc. as of December 31, 2012 and 2011 and for the year ended December 31, 2012, the period from January 18, 2011 (inception) through December 31, 2011, and the period from January 18, 2011 (inception) through December 31, 2012",
"Unaudited Financial Statements of Phyxius Pharma, Inc. as of September 30, 2013 and December 31, 2012 and for the nine months ended September 30, 2013 and 2012 and the period from January 18, 2011 (inception) through September 30, 2013",
"Unaudited Pro Forma Condensed Combined Financial Information of Oxygen Biotherapeutics, Inc. as of and for the six months ended October 31, 2013 and the unaudited pro forma condensed combined statement of operations of the Company for the year ended April 30, 2013" |
|
| 12/20/2013 |
8-K/A
| Submission of Matters to a Vote of Security Holders |
| 07/30/2013 |
8-K/A
| Other Events |
| 02/27/2013 |
8-K/A
| Financial Statements and Exhibits |
| 12/12/2011 |
8-K/A
| Financial Statements and Exhibits |
| 08/26/2011 |
8-K/A
| Form 8-K/A - Current report [Amend] |
| 07/01/2011 |
8-K/A
| Form 8-K/A - Current report [Amend] |
| 05/07/2010 |
8-K/A
| Form 8-K/A - Current report [Amend] |
| 01/27/2009 |
8-K/A
| Form 8-K/A - Current report [Amend] |
| 10/03/2008 |
8-K/A
| Form 8-K/A - Current report [Amend] |
|
|